TradingMula

Vir Gets Funding From GSK

Long
NASDAQ:VIR   Vir Biotechnology, Inc.
Target $36 or 15% upside

Like, comment or follow if you like my ideas!
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.